Axicabtagene ciloleucel,Cyclophosphamide,Fludarabine
gilead
['yescarta', 'lymphoma', 'gilead', '$gild']
gilead's yescarta cuts risk of death by 27.4% in lymphoma study $gild #asco23 
The latest global #pharma news, insights, analysis, and views providing you with an information edge.  FirstWord Pharma. Where people who know first, go first.